Jones Trading Maintains Buy on Definium Therapeutics, Raises Price Target to $74
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $61 to $74.
Jones Trading analyst Justin Walsh maintains Definium Therapeutics (NASDAQ:DFTX) with a Buy and raises the price target from $61 to $74.